SPHEROCYTOSIS, TYPE 1 (disorder)

Known as: SPH1, HS1, Congenital Spherocytic Hemolytic Anemia 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Sphingoid intermediates accumulate in response to a variety of stresses, including heat, and trigger cellular responses. However… (More)
  • table 1
  • table 2
Is this relevant?
2006
2006
Five experiments were conducted to test the effects of various dietary humic substances (HS; HS1, 2, 3, and 4, each with… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
This paper presents the implementation of an adaptive smoothed particle hydrodynamics (ASPH) method for high strain Lagrangian… (More)
  • figure 2
  • figure 1
  • figure 3
  • table 1
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Objectives were to determine factors associated with conception rate (CR) and pregnancy loss (PL) in high producing lactating… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVES Sphingosine 1-phosphate (Sph-1-P), a bioactive lipid derived from activated platelets, may play an important role in… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Laccase oxidation of phenolic azo dyes was examined with a commercially available laccase from Pyricularia oryzae as the model… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Activation of the PDGF receptor on human arterial smooth muscle cells (SMC) induces migration and proliferation via separable… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1993
Highly Cited
1993
We have tested the effect of the individual DNase I hypersensitive site (HS) regions of the globin locus control region (LCR) on… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Sphingosine 1-phosphate (Sph-1-P), the initial product of Sph degradation by Sph kinase, was shown to be a strong inhibitor of… (More)
Is this relevant?